Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Bay-x-3702: Neuroprotective 5-HT1A receptor agonist from Bayer

March 24, 1997

Dual NOS/COX inhibitors claimed by SCRAS

March 24, 1997

New salts of known antimigraine agent from Glaxo Wellcome

March 24, 1997

5-HT1A antagonists from American Home Products

March 24, 1997

SCRAS describes galanthamine derivatives

March 24, 1997

Quadramet enters phase I for arthritis

March 21, 1997

FDA clears midazolam for use in children

March 21, 1997

3-D structure of adenylyl cyclase core determined

March 21, 1997

Sagami prepares angiotensin IV agonists

March 21, 1997

Antihyperalgesic effects of bradykinin B2 antagonist from Fujisawa

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...